Bill Sponsor
House Bill 5632
117th Congress(2021-2022)
Long-Term Care Pharmacy Definition Act of 2021
Introduced
Introduced
Introduced in House on Oct 19, 2021
Overview
Text
Introduced in House 
Oct 19, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Oct 19, 2021)
Oct 19, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 5632 (Introduced-in-House)


117th CONGRESS
1st Session
H. R. 5632


To codify a statutory definition for long-term care pharmacies.


IN THE HOUSE OF REPRESENTATIVES

October 19, 2021

Mr. Schrader (for himself and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To codify a statutory definition for long-term care pharmacies.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Long-Term Care Pharmacy Definition Act of 2021”.

SEC. 2. Definition.

Section 1860D–2 of the Social Security Act (42 U.S.C. 1395w–102) is amended by adding at the end the following new subsection:

“(f) Long-Term care pharmacy defined.—

“(1) IN GENERAL.—The term ‘long-term care pharmacy’ means a pharmacy licensed under applicable State law that is able to provide enhanced pharmacy and clinical services to individuals who require enhanced medication services and reside in a facility (as defined in paragraph (4)).

“(2) ENHANCED PHARMACY AND CLINICAL SERVICES.—As used in this subsection, the term ‘enhanced pharmacy and clinical services’ includes—

“(A) medications dispensed pursuant to a prescription or chart order in specialized packaging which shall include unit of use packaging, unit dose packaging, single use containers, packaging from remote automated dispensing technology, or other packaging required;

“(B) drug utilization review to identify potential adverse drug reactions and inappropriate drug usage;

“(C) medication reconciliation services at the transition of care and other necessary clinical management and medication services;

“(D) timely medication delivery 24 hours a day, 7 days a week;

“(E) pharmacist on-call availability to provider dispensing and clinical services 24 hours a day, 7 days a week;

“(F) emergency supplies of medication as permitted by law and as required, including emergency kits or remote automated dispensing technology at a facility; and

“(G) such other services as the Secretary determines appropriate.

“(3) INDIVIDUALS REQUIRING ENHANCED MEDICATION SERVICES.—As used in this subsection, the term ‘individual who requires enhanced medication services’ means an individual who has one or more comorbid and medically complex chronic conditions that are life-threatening or significantly limit overall health or function, pose a high risk of hospitalization or other adverse health outcomes, and require enhanced pharmacy and clinical services.

“(4) FACILITY.—As used in this subsection, the term ‘facility’ includes a facility described in section 1819(a), 1919(a), or 1905(d), or any other setting in which individuals who require enhanced medication services reside as determined by the Secretary.”.